Sains Malaysiana 54(4)(2025): 1005-1024

http://doi.org/10.17576/jsm-2025-5404-04

 

IL-1β Expression and Change Following SRP in Gingival Crevicular Fluid in Patients with Periodontitis: A Systematic Review and Meta-Analysis

(Pengekspresan dan Perubahan IL-1β Mengikuti SRP dalam Cecair Krevikular Gingival pada Pesakit dengan Periodontitis: Suatu Kajian Sistematik dan Meta-Analisis)

 

JUAN WANG^1,2, QING LIU¹, JINPIN YU¹, JIALING LI³, BIN CHEN^1,* & YINGCHUN DONG¹

 

¹Department of Periodontology, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing, Jiangsu, China

²Haixiacheng Community Health Service Centre, Jianye District, Nanjing, China

³Department of Orthodontics, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing, Jiangsu, China

 

Diserahkan: 27 September 2024/ Diterima: 16 Disember 2024

 

Abstract

Periodontitis is a chronic inflammatory periodontal lesion, characterised by progressive destruction of connective tissue and continuous loss of marginal bone surrounding the teeth. Cytokines and chemokines play a role in the pathogenesis of chronic periodontitis (CP). Among these, IL-1β is considered one of the most important inflammatory factors and tissue-destructive cytokines. Despite numerous investigations identifying the role of IL-1β in gingival crevicular fluid (GCF) in bone resorption and connective tissue destruction, the efficacy of GCF IL-1β in assisting the diagnosis and predicting the progression of CP remains undetermined. The objective of this study was to ascertain whether IL-1β can be used as a diagnostic and progressive biomarker for CP. To this end, GCF IL-1β levels were compared between periodontally healthy controls and subjects diagnosed with CP, as well as between subjects before and after scaling and root planning (SRP) for CP. Additionally, the correlations between GCF IL-1β levels and various clinical parameters, including probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP), plaque index (PI), and gingival index (GI), were analysed within the CP group. A comprehensive search of the PubMed, Embase and Cochrane databases was conducted from their inception up to 1 April 2022. The electronic search terms employed were ‘periodontitis OR periodontal diseases’ AND ‘Interleukin-1β OR IL-1β’ AND ‘gingival crevicular fluid’. The review includes cross-sectional, case series, single arm studies, prospective and retrospective cohort studies, as well as randomised controlled trials (RCTs) and non-RCTs. The studies that compared IL-1β levels (either the concentration or the total amount) between healthy controls and subjects with CP, or between subjects with CP before and after SRP, were included in the review. The meta-analysis was conducted using Review Manager 5.3. The analysis included data from 50 studies comprising 1,502 patients. The concentration, total amount of GCF IL-1β, and GCF volume in subjects with CP were found to be significantly higher than in healthy controls (P < 0.01). The concentrations of GCF IL-1β in CP group decreased significantly at 1 month (P = 0.04), 1.5 months and 3 months following SRP compared with the preoperative baseline (P < 0.01). The total amounts of GCF IL-1β in CP group decreased significantly at postoperative 1 month, 1.5 months, 3 months, and 6 months compared with the baseline, and the P-values are all less than 0.01 except P =0.02 for 1.5 months. GCF volumes in CP group decreased significantly at 1 months, 3 months, and 6 months following SRP compared with the baseline (P < 0.01). The total amount of GCF IL-1β was found to be correlated positively and closely with BOP (r=0.894, P=0.041) in CP group. No significant correlations were identified between the total amount of IL-1β and other clinical parameters, nor between the concentration of IL-1β and any clinical parameter (P > 0.05). GCF IL-1β may serve as a diagnostic and progressive biomarker of chronic periodontitis (CP). The measurement of GCF IL-1β levels may prove beneficial in the diagnosis of initial periodontitis, the assessment of the therapeutic efficacy of SRP for CP, the determination of disease severity and activity, and the prediction of CP progression. 

Keywords: Chronic periodontitis; gingival crevicular fluid; IL-1β; periodontal diseases; scaling & root planning

Abstrak

Periodontitis adalah lesi periodontal radang kronik, dicirikan oleh kemusnahan progresif tisu penghubung dan kehilangan berterusan tulang marginal di sekeliling gigi. Sitokin dan kemokin memainkan peranan dalam patogenesis periodontitis kronik (CP). Antaranya, IL-1β dianggap sebagai salah satu faktor keradangan yang paling penting dan sitokin yang merosakkan tisu. Walaupun banyak penyelidikan mengenal pasti peranan IL-1β dalam cecair krevikular gingival (GCF) dalam penyerapan tulang dan pemusnahan tisu penghubung, keberkesanan GCF IL-1β dalam membantu diagnosis dan meramalkan perkembangan CP masih tidak dapat ditentukan. Objektif kajian ini adalah untuk memastikan sama ada IL-1β boleh digunakan sebagai biopenanda diagnostik dan progresif untuk CP. Untuk tujuan ini, tahap GCF IL-1β dibandingkan antara kawalan sihat periodontal dan subjek yang didiagnosis dengan CP, serta antara subjek sebelum dan selepas penskalaan dan perancangan akar (SRP) untuk CP. Selain itu, korelasi antara tahap GCF IL-1β dan pelbagai parameter klinikal, termasuk kedalaman probing (PD), tahap lampiran klinikal (CAL), pendarahan semasa probing (BOP), indeks plak (PI) dan indeks gingival (GI) dianalisis dalam kumpulan CP. Carian komprehensif bagi pangkalan data PubMed, Embase dan Cochrane telah dijalankan daripada penubuhannya sehingga 1 April 2022. Istilah carian elektronik yang digunakan ialah 'periodontitis ATAU penyakit periodontal' DAN 'Interleukin-1β ATAU IL-1β' DAN 'cecair krevikular gingiva'. Kajian itu termasuk keratan rentas, siri kes, kajian lengan tunggal, kajian kohort prospektif dan retrospektif, serta ujian terkawal rawak (RCT) dan bukan RCT. Kajian yang membandingkan tahap IL-1β (sama ada kepekatan atau jumlah keseluruhan) antara kawalan sihat dan subjek dengan CP atau antara subjek dengan CP sebelum dan selepas SRP telah dimasukkan dalam semakan. Meta-analisis telah dijalankan menggunakan Pengurus Kajian 5.3. Analisis termasuk data daripada 50 kajian yang terdiri daripada 1,502 pesakit. Kepekatan, jumlah amaun GCF IL-1β dan GCF dalam subjek dengan CP didapati jauh lebih tinggi daripada kawalan sihat (P <0.01). Kepekatan GCF IL-1β dalam kumpulan CP menurun dengan ketara pada 1 bulan (P = 0.04), 1.5 bulan dan 3 bulan selepas SRP berbanding dengan garis dasar praoperasi (P <0.01). Jumlah keseluruhan GCF IL-1β dalam kumpulan CP menurun dengan ketara pada 1 bulan, 1.5 bulan, 3 bulan dan 6 bulan selepas operasi berbanding dengan garis dasar dan nilai-P semuanya kurang daripada 0.01 kecuali P = 0.02 selama 1.5 bulan. Jumlah GCF dalam kumpulan CP menurun dengan ketara pada 1 bulan, 3 bulan dan 6 bulan selepas SRP berbanding dengan garis dasar (P <0.01). Jumlah keseluruhan GCF IL-1β didapati berkorelasi secara positif dan rapat dengan BOP (r=0.894, P=0.041) dalam kumpulan CP. Tiada korelasi yang ketara dikenal pasti antara jumlah IL-1β dan parameter klinikal lain, mahupun antara kepekatan IL-1β dan mana-mana parameter klinikal (P > 0.05). GCF IL-1β boleh berfungsi sebagai biopenanda diagnostik dan progresif periodontitis kronik (CP). Pengukuran tahap GCF IL-1β mungkin terbukti bermanfaat dalam diagnosis periodontitis awal, penilaian keberkesanan terapeutik SRP untuk CP, penentuan keterukan dan aktiviti penyakit serta ramalan perkembangan CP.

Kata kunci: Cecair krevikal gingiva; IL-1β; penskalaan & perancangan akar; penyakit periodontal; periodontitis kronik

 

RUJUKAN

Abduljabbar, T., Vohra, F., Kellesarian, S.V. & Javed, F. 2017. Efficacy of scaling and root planning with and without adjunct Nd:YAG laser therapy on clinical periodontal parameters and gingival crevicular fluid interleukin 1-β and tumor necrosis factor-α levels among patients with periodontal disease: A prospective randomized split-mouth clinical study. J. Photochem. Photobiol. B 169: 70-74. doi:10.1016/j.jphotobiol.2017.03.001

Akram, Z., Abduljabbar, T., Abu Hassan, M.I., Javed, F. & Vohra, F. 2016. Cytokine profile in chronic periodontitis patients with and without obesity: A systematic review and meta-analysis. Dis. Markers 2016: 4801418. doi:10.1155/2016/4801418

Albandar, J.M. 2014. Aggressive periodontitis: Case definition and diagnostic criteria. Periodontol. 2000 65(1): 13-26. doi:10.1111/prd.12014

Alexander, D.C., Martin, J.C., King, P.J., Powell, J.R., Caves, J. & Cohen, M.E. 1996. Interleukin-1β, prostaglandin E2, and immunoglobulin G subclasses in gingival crevicular fluid in patients undergoing periodontal therapy. J. Periodontol. 67(8): 755-762. doi:10.1902/jop.1996.67.8.755

Ambrósio, L.M., Rovai, E.S., França, B.N., Balzarini, D.A., Abreu, I.S., Lopes, S.B., Nunes, T.B., Lourenço, S.V., Pasoto, S.G., Saraiva, L. & Holzhausen, M. 2017. Effects of periodontal treatment on primary sjȫgren's syndrome symptoms. Braz. Oral. Res. 31: e8. doi:10.1590/1807-3107BOR-2017.vol31.0008

Armitage, G.C. 2004. The complete periodontal examination. Periodontol. 2000 34: 22-33. doi:10.1046/j.0906-6713.2002.003422.x

Becerik, S., Ozturk, V.O., Atmaca, H., Atilla, G. & Emingil, G. 2012. Gingival crevicular fluid and plasma acute-phase cytokine levels in different periodontal diseases. J. Periodontol. 83(10): 1304-1313. doi:10.1902/jop.2012.110616

Bolyarova-Konova, T., Petkova, S., Mihaylova, H., Velikova, T., Ivanova-Todorova, E., Tumangelova-Yuzeir, K. & Todorova, D. 2020. Concentrations of interleukin-1ß in gingival crevicular fluid and saliva - A potential diagnostic biomarker of periodontal diseases. Folia Medica 62(4): 825-830. doi:10.3897/folmed.62.e49872

Buduneli, N., Buduneli, E., Cetin, E.O., Kirilmaz, L. & Kütükçüler, N. 2010. Clinical findings and gingival crevicular fluid prostaglandin E2 and interleukin-1-ß levels following initial periodontal treatment and short-term meloxicam administration. Expert Opin. Pharmacother. 11(11): 1805-1812. doi:10.1517/14656566.2010.490555

Bulut, U., Develioglu, H., Taner, I.L. & Berker, E. 2001. Interleukin-1β levels in gingival crevicular fluid in type 2 diabetes mellitus and adult periodontitis. J. Oral. Sci. 43(3): 171-177. doi:10.2334/josnusd.43.171

Cetinkaya, B., Guzeldemir, E., Ogus, E. & Bulut, S. 2013. Proinflammatory and anti-inflammatory cytokines in gingival crevicular fluid and serum of patients with rheumatoid arthritis and patients with chronic periodontitis. J. Periodontol. 84(1): 84-93. doi:10.1902/jop.2012.110467

Chang, S.M. 2011. The Agency for Healthcare Research and Quality (AHRQ) Effective Health Care (EHC) program methods guide for comparative effectiveness reviews: Keeping up-to-date in a rapidly evolving field. J. Clin. Epidemiol. 64(11): 1166-1167. doi:10.1016/j.jclinepi.2011.08.004

Chaudhari, A.U., Byakod, G.N., Waghmare, P.F. & Karhadkar, V.M. 2011. Correlation of levels of interleukin-1β in gingival crevicular fluid to the clinical parameters of chronic periodontitis. J. Contemp. Dent. Pract. 12(1): 52-59. doi:10.5005/jp-journals-10024-1010

Cheng, P.H., Qi, X.M. & Du, Z.X. 2010. Effect of periodontal initial therapy together with Chinese herbal compound for clearing heat and detoxification on interleukin-1β and tumor necrosis factor-α in gingival crevicular fluid of patients with chronic periodontitis. Zhongguo Zhong Xi Yi Jie He Za Zhi 30(3): 268-270.

Cox, C. 2021. Bead-based multiplex immunoassays: Procedures, tips, and tricks. Methods Mol. Biol. 2261: 263-276. doi:10.1007/978-1-0716-1186-9_16

Cutler, C.W., Machen, R.L., Jotwani, R. & Iacopino, A.M. 1999. Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia. J. Periodontol. 70(11): 1313-1321. doi:10.1902/jop.1999.70.11.1313

Eltas, A. & Orbak, R. 2012. Effect of 1,064-nm Nd:YAG laser therapy on GCF IL-1β and MMP-8 levels in patients with chronic periodontitis. Lasers Med. Sci. 27(3): 543-550. doi:10.1007/s10103-011-0939-5

Engebretson, S.P., Grbic, J.T., Singer, R. & Lamster, I.B. 2002. GCF IL-1β profiles in periodontal disease. J. Clin. Periodontol. 29(1): 48-53. doi:10.1034/j.1600-051x.2002.290108.x

Erbil, D., Nazaroglu, K., Baser, U., Issever, H., Mese, S. & Isik, A.G. 2020. Clinical and immunological effects of Er,Cr:YSGG laser in nonsurgical periodontal treatment: A randomized clinical trial. Photobiomodul. Photomed. Laser Surg. 38(5): 316-322. doi:10.1089/photob.2019.4748

Escalona, L.A., Mastromatteo-Alberga, P. & Correnti, M. 2016. Cytokine and metalloproteinases in gingival fluid from patients with chronic periodontitis. Investigacion Clinica (Venezuela) 57(2): 131-142.

Faizuddin, M., Bharathi, S.H. & Rohini, N.V. 2003. Estimation of interleukin-1β levels in the gingival crevicular fluid in health and in inflammatory periodontal disease. J. Periodontal. Res. 38(2): 111-114. doi:10.1034/j.1600-0765.2003.01649.x

Fatima, T., Khurshid, Z., Rehman, A., Imran, E., Srivastava, K.C. & Shrivastava, D. 2021. Gingival crevicular fluid (GCF): A diagnostic tool for the detection of periodontal health and diseases. Molecules 26(5): 1208. doi:10.3390/molecules26051208

Fatimah Maria Tadjoedin, A.H.F., Sandra Olivia Kuswandani, Benso Sulijaya & Yuniarti Soeroso. 2017. The correlation between age and periodontal diseases. Journal of International Dental and Medical Research 10(2): 327-332.

Fujita, Y., Ito, H., Sekino, S. & Numabe, Y. 2012. Correlations between pentraxin 3 or cytokine levels in gingival crevicular fluid and clinical parameters of chronic periodontitis. Odontology 100(2): 215-221. doi:10.1007/s10266-011-0042-1

Gamonal, J., Acevedo, A., Bascones, A., Jorge, O. & Silva, A. 2000. Levels of interleukin-1β, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J. Periodontol. 71(10): 1535-1545. doi:10.1902/jop.2000.71.10.1535

Gao, Y. & Hao, C.D. 2018. Expression of miR-146a in saliva of chronic periodontitis patients and its influence on gingival crevicular inflammation and MMP-8/TIMP-1 levels. Shanghai Kou Qiang Yi Xue 27(3): 309-312.

Görgün, E.P., Toker, H. & Poyraz, Ö. 2021. Effect of non-surgical periodontal treatment on gingival crevicular fluid interleukin-1β and interleukin-37 in different periodontal diseases. Meandros Medical and Dental Journal 22(1): 110-118. doi:10.4274/MEANDROS.GALENOS.2021.09821

Goutoudi, P., Diza, E. & Arvanitidou, M. 2004. Effect of periodontal therapy on crevicular fluid interleukin-1β and interleukin-10 levels in chronic periodontitis. J. Dent. 32(7): 511-520. doi:10.1016/j.jdent.2004.04.003

Gündoğar, H., Şenyurt, S.Z., Erciyas, K., Yalım, M. & Üstün, K. 2016. The effect of low-level laser therapy on non-surgical periodontal treatment: A randomized controlled, single-blind, split-mouth clinical trial. Lasers in Medical Science 31(9): 1767-1773. doi:10.1007/s10103-016-2047-z

Habashneh, R.A., Mashal, M.A., Khader, Y. & Qudah, R. 2019. Clinical and biological effects of adjunctive photodynamic therapy in refractory periodontitis. J. Lasers Med. Sci. 10(2): 139-145. doi:10.15171/jlms.2019.22

Haffajee, A.D. & Socransky, S.S. 2001. Relationship of cigarette smoking to attachment level profiles. J. Clin. Periodontol. 28(4): 283-295. doi:10.1034/j.1600-051x.2001.028004283.x

Higgins, J.P. & Thompson, S.G. 2002. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21(11): 1539-1558. doi:10.1002/sim.1186

Higgins, J.P.T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M.J. & Welch, V.A. 2019. Cochrane Handbook for Systematic Reviews of Interventions. 2nd ed. Chichester (UK): John Wiley & Sons.

Hou, L.T., Liu, C.M. & Rossomando, E.F. 1995. Crevicular interleukin-1β in moderate and severe periodontitis patients and the effect of phase I periodontal treatment. J. Clin. Periodontol. 22(2): 162-167. doi:10.1111/j.1600-051x.1995.tb00128.x

Hu, S.C., Shu, R., Song, Z.C., Sun, M.J. & Wang, Y.W. 2017. Clinical effects of photo-activated disinfection as an adjunctive therapy for the treatment of chronic periodontitis. Journal of Shanghai Jiaotong University (Medical Science) 37(5): 621-626. doi:10.3969/j.issn.1674-8115.2017.05.010

Jacob, P.S., Nath, S. & Patel, R.P. 2014. Evaluation of interleukin-1β and 8 in gutka chewers with periodontitis among a rural Indian population. J. Periodontal Implant. Sci. 44(3): 126-133. doi:10.5051/jpis.2014.44.3.126

Javed, F., Al-Askar, M., Samaranayake, L.P. & Al-Hezaimi, K. 2013. Periodontal disease in habitual cigarette smokers and nonsmokers with and without prediabetes. Am. J. Med. Sci. 345(2): 94-98. doi:10.1097/MAJ.0b013e31824d5337

Keles Yucel, Z.P., Afacan, B., Atmaca Ilhan, H., Kose, T. & Emingil, G. 2022. The trefoil factor family 1 (TFF-1) and 3 (TFF-3) are upregulated in the saliva, gingival crevicular fluid and serum of periodontitis patients. Oral Dis. 28(4): 1240-1249. doi:10.1111/odi.13820

Koidou, V.P., Cavalli, N., Hagi-Pavli, E., Nibali, L. & Donos, N. 2020. Expression of inflammatory biomarkers and growth factors in gingival crevicular fluid at different healing intervals following non-surgical periodontal treatment: A systematic review. J. Periodontal Res. 55(6): 801-809. doi:10.1111/jre.12795

Konopka, L., Pietrzak, A. & Brzezińska-Błaszczyk, E. 2012. Effect of scaling and root planing on interleukin-1β, interleukin-8 and MMP-8 levels in gingival crevicular fluid from chronic periodontitis patients. J. Periodontal Res. 47(6): 681-688. doi:10.1111/j.1600-0765.2012.01480.x

Kozak, M., Dabrowska-Zamojcin, E., Mazurek-Mochol, M. & Pawlik, A. 2020. Cytokines and their genetic polymorphisms related to periodontal disease. J. Clin. Med. 9(12): 4045. doi:10.3390/jcm9124045

Liu, C.M., Hou, L.T., Wong, M.Y. & Lan, W.H. 1999. Comparison of Nd:YAG laser versus scaling and root planing in periodontal therapy. J. Periodontol. 70(11): 1276-1282. doi:10.1902/jop.1999.70.11.1276

Lu, H.K. & Chei, C.J. 2005. Efficacy of subgingivally applied minocycline in the treatment of chronic periodontitis. J. Periodontal Res. 40(1): 20-27. doi:10.1111/j.1600-0765.2004.00763.x

Lui, J., Corbet, E.F. & Jin, L. 2011. Combined photodynamic and low-level laser therapies as an adjunct to nonsurgical treatment of chronic periodontitis. J. Periodontal Res. 46(1): 89-96. doi:10.1111/j.1600-0765.2010.01316.x

Luo, D., Wan, X., Liu, J. & Tong, T. 2018. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat. Methods Med. Res. 27(6): 1785-1805. doi:10.1177/0962280216669183

Miyazaki, A., Yamaguchi, T., Nishikata, J., Okuda, K., Suda, S., Orima, K., Kobayashi, T., Yamazaki, K., Yoshikawa, E. & Yoshie, H. 2003. Effects of Nd:YAG and CO₂ laser treatment and ultrasonic scaling on periodontal pockets of chronic periodontitis patients. J. Periodontol. 74(2): 175-180. doi:10.1902/jop.2003.74.2.175

Mogi, M., Otogoto, J., Ota, N., Inagaki, H., Minami, M. & Kojima, K. 1999. Interleukin 1β, interleukin 6, β2-microglobulin, and transforming growth factor-α in gingival crevicular fluid from human periodontal disease. Arch. Oral. Biol. 44(6): 535-539. doi:10.1016/s0003-9969(99)00020-5

Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G. & Group, P. 2009. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 339: b2535. doi:10.1136/bmj.b2535

Norris, J.M., Simpson, B.S., Ball, R., Freeman, A., Kirkham, A., Parry, M.A., Moore, C.M., Whitaker, H.C. & Emberton, M. 2021. A modified Newcastle-Ottawa scale for assessment of study quality in genetic urological research. Eur. Urol. 79(3): 325-326. doi:10.1016/j.eururo.2020.12.017

Oh, H., Hirano, J., Takai, H. & Ogata, Y. 2015. Effects of initial periodontal therapy on interleukin-1β level in gingival crevicular fluid and clinical periodontal parameters. J. Oral Sci. 57(2): 67-71. doi:10.2334/josnusd.57.67

Overmyer, K.A., Rhoads, T.W., Merrill, A.E., Ye, Z., Westphall, M.S., Acharya, A., Shukla, S.K. & Coon, J.J. 2021. Proteomics, lipidomics, metabolomics, and 16S DNA sequencing of dental plaque from patients with diabetes and periodontal disease. Mol. Cell Proteomics 20: 100126. doi:10.1016/j.mcpro.2021.100126

Papapanou, P.N., Sanz, M., Buduneli, N., Dietrich, T., Feres, M., Fine, D.H., Flemmig, T.F., Garcia, R., Giannobile, W.V., Graziani, F., Greenwell, H., Herrera, D., Kao, R.T., Kebschull, M., Kinane, D.F., Kirkwood, K.L., Kocher, T., Kornman, K.S., Kumar, P.S., Loos, B.G., Machtei, E., Meng, H., Mombelli, A., Needleman, I., Offenbacher, S., Seymour, G.J., Teles, R. & Tonetti, M.S. 2018. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the classification of periodontal and peri-implant diseases and conditions. J. Periodontol. 89(Suppl 1): S173-S182. doi:10.1002/JPER.17-0721

Patel, R.P., Amirisetty, R., Kalakonda, B., Penumatsa, N.V. & Koppolu, P. 2018. Influence of smoking on gingival crevicular fluid interleukin 1β and interleukin-8 in patients with severe chronic periodontitis among a rural population in India. Niger. Med. J. 59(4): 33-38. doi:10.4103/nmj.NMJ_142_17

Preshaw, P.M. & Taylor, J.J. 2011. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J. Clin. Periodontol. 38(Suppl 11): 60-84. doi:10.1111/j.1600-051X.2010.01671.x

Rabelo, M.D.S., Gomes, G.H., Foz, A.M., Stadler, A.F., Cutler, C.W., Susin, C. & Romito, G.A. 2021. Short-term effect of non-surgical periodontal treatment on local and systemic cytokine levels: Role of hyperglycemia. Cytokine 138: 155360. doi:10.1016/j.cyto.2020.155360

Rawlinson, A., Grummitt, J.M., Walsh, T.F. & Ian Douglas, C.W. 2003. Interleukin 1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non-smokers. J. Clin. Periodontol. 30(1): 42-48. doi:10.1034/j.1600-051x.2003.300107.x

Reddy, M.S. 1997. The use of periodontal probes and radiographs in clinical trials of diagnostic tests. Ann. Periodontol. 2(1): 113-122. doi:10.1902/annals.1997.2.1.113

Sağlam, M., Köseoğlu, S., Taşdemir, I., Erbak Yılmaz, H., Savran, L. & Sütçü, R. 2017. Combined application of Er:YAG and Nd:YAG lasers in treatment of chronic periodontitis. A split-mouth, single-blind, randomized controlled trial. J. Periodontal. Res. 52(5): 853-862. doi:10.1111/jre.12454

Saglam, M., Kantarci, A., Dundar, N. & Hakki, S.S. 2014. Clinical and biochemical effects of diode laser as an adjunct to nonsurgical treatment of chronic periodontitis: A randomized, controlled clinical trial. Lasers Med. Sci. 29(1): 37-46. doi:10.1007/s10103-012-1230-0

Sezen, D., Hatipoglu, M. & Ustun, K. 2020. Evaluation of the clinical and biochemical efficacy of erbium, chromium:ytrium-scandium-gallium-garnet (ER,CR:YSGG) laser treatment in periodontitis. Lasers Med. Sci. 35(7): 1567-1575. doi:10.1007/s10103-020-02990-8

Shimada, Y., Tabeta, K., Sugita, N. & Yoshie, H. 2013. Profiling biomarkers in gingival crevicular fluid using multiplex bead immunoassay. Arch. Oral Biol. 58(6): 724-730. doi:10.1016/j.archoralbio.2012.11.012

Slim, K., Nini, E., Forestier, D., Kwiatkowski, F., Panis, Y. & Chipponi, J. 2003. Methodological index for non-randomized studies (minors): Development and validation of a new instrument. ANZ J. Surg. 73(9): 712-716. doi:10.1046/j.1445-2197.2003.02748.x

Stadler, A.F., Angst, P.D., Arce, R.M., Gomes, S.C., Oppermann, R.V. & Susin, C. 2016. Gingival crevicular fluid levels of cytokines/chemokines in chronic periodontitis: A meta-analysis. J. Clin. Periodontol. 43(9): 727-745. doi:10.1111/jcpe.12557

Stang, A. 2010. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25(9): 603-605. doi:10.1007/s10654-010-9491-z

Tasdemir, Z., Oskaybas, M.N., Alkan, A.B. & Cakmak, O. 2019. The effects of ozone therapy on periodontal therapy: A randomized placebo-controlled clinical trial. Oral Dis. 25(4): 1195-1202. doi:10.1111/odi.13060

Teymouri, F., Farhad, S.Z. & Golestaneh, H. 2016. The effect of photodynamic therapy and diode laser as adjunctive periodontal therapy on the inflammatory mediators levels in gingival crevicular fluid and clinical periodontal status. J. Dent. (Shiraz) 17(3): 226-232.

Thunell, D.H., Tymkiw, K.D., Johnson, G.K., Joly, S., Burnell, K.K., Cavanaugh, J.E., Brogden, K.A. & Guthmiller, J.M. 2010. A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy. J. Periodontal. Res. 45(1): 148-152. doi:10.1111/j.1600-0765.2009.01204.x

Toker, H., Akpınar, A., Aydın, H. & Poyraz, O. 2012. Influence of smoking on interleukin-1β level, oxidant status and antioxidant status in gingival crevicular fluid from chronic periodontitis patients before and after periodontal treatment. J. Periodontal Res. 47(5): 572-577. doi:10.1111/j.1600-0765.2012.01468.x

Tsai, C.C., Ho, Y.P. & Chen, C.C. 1995. Levels of interleukin-1β and interleukin-8 in gingival crevicular fluids in adult periodontitis. J. Periodontol. 66(10): 852-859. doi:10.1902/jop.1995.66.10.852

Tüter, G., Kurtiş, B. & Serdar, M. 2001. Interleukin-1β and thiobarbituric acid reactive substance (TBARS) levels after phase I periodontal therapy in patients with chronic periodontitis. J. Periodontol. 72(7): 883-888. doi:10.1902/jop.2001.72.7.883

Uraz, A., Ayhan, E., Yildirim, B., Bariş, E., Pehlivan, S. & Eren, K. 2013. Immunoexpression of p38 mitogen-activated proteinkinase in patients with aggressive and chronic periodontitis. European Journal of Inflammation 11(1): 33-41. doi:10.1177/1721727X1301100104

Üstün, K., Erciyas, K., Sezer, U., Şenyurt, S.Z., Gündoğar, H., Üstün, Ö. & Öztuzcu, S. 2014. Clinical and biochemical effects of 810 nm diode laser as an adjunct to periodontal therapy: A randomized split-mouth clinical trial. Photomed. Laser Surg. 32(2): 61-66. doi:10.1089/pho.2013.3506

Ustun, K., Hatipoglu, M., Daltaban, O., Felek, R. & Firat, M.Z. 2018. Clinical and biochemical effects of erbium, chromium: yttrium, scandium, gallium, garnet laser treatment as a complement to periodontal treatment. Niger. J. Clin. Pract. 21(9): 1150-1157. doi:10.4103/njcp.njcp_51_18

Viswanathan, M., Ansari, M.T., Berkman, N.D., Chang, S., Hartling, L., McPheeters, M., Santaguida, P.L., Shamliyan, T., Singh, K., Tsertsvadze, A. & Treadwell, J.R. 2008. Assessing the risk of bias of individual studies in systematic reviews of health care interventions. In Methods Guide for Effectiveness and Comparative Effectiveness Reviews [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US).

Wan, X., Wang, W., Liu, J. & Tong, T. 2014. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med. Res. Methodol. 14: 135. doi:10.1186/1471-2288-14-135

Wei, P.F., Ho, K.Y., Ho, Y.P., Wu, Y.M., Yang, Y.H. & Tsai, C.C. 2004. The investigation of glutathione peroxidase, lactoferrin, myeloperoxidase and interleukin-1β in gingival crevicular fluid: Implications for oxidative stress in human periodontal diseases. J. Periodontal Res. 39(5): 287-293. doi:10.1111/j.1600-0765.2004.00744.x

Wu, Y.F., Tan, C., Zhang, J.Y., Meng, S. & Guo, Y.H. 2004. Interleukin-1β and IL-1 receptor antagonist levels in gingival crevicular fluid and their relationship to clinical indices of periodontitis. Journal of Sichuan University (Medical Science Edition) 35(5): 683-686.

Yücel, O.O., Berker, E., Gariboğlu, S. & Otlu, H. 2008. Interleukin-11, interleukin-1β, interleukin-12 and the pathogenesis of inflammatory periodontal diseases. J. Clin. Periodontol 35(5): 365-370. doi:10.1111/j.1600-051X.2008.01212.x

Zhang, J., Kashket, S. & Lingstrom, P. 2002. Evidence for the early onset of gingival inflammation following short-term plaque accumulation. J. Clin. Periodontol. 29(12): 1082-1085. doi:10.1034/j.1600-051x.2002.291206.x

Zhu, H., Lin, X., Zheng, P. & Chen, H. 2015. Inflammatory cytokine levels in patients with periodontitis and/or coronary heart disease. Int. J. Clin. Exp. Pathol. 8(2): 2214-2220.

 

*Pengarang untuk surat-menyurat; email: 361734128@qq.com